Marksans Pharma financials at a glance

+ Portfolio

The revenue of Marksans Pharma is reported as 21.58339 billion Rupees in the fiscal year 2024. The earnings were 7.36 Rupees per share in 2024, which was 133.75 higher than 2018. And about 0 billion Rupees are reported as free cash flow in the financials of Marksans Pharma 2024. Dividends of 0 Rupees per share were paid to shareholders of Marksans Pharma stock NSEI:MARKSANS in fiscal 2024.

Forecast

Financials

Year	Year	TTM	2019	2018	2017	2016
Rev.	Revenue	N/A	Rp10.00B	Rp9.13B	Rp7.74B	Rp9.02B
GM %	Gross Margin %	50.05%	49.19%	41.68%	38.88%	41.66%
OM	Operating Margin	17.25%	11.23%	6.52%	0.37%	11.67%
EPS	Earnings Per Share	Rp6.75	Rp1.87	Rp0.80	Rp0.23	Rp2.02
Div.	Dividends	N/A	Rp0.00	Rp0.05	Rp0.05	Rp0.12
PR %	Payout Ratio %	0	0	6.25%	21.74%	5.94%
Sha.	Shares	N/AM	409.31M	409.31M	409.31M	409.31M
OCF	Operating Cash Flow	N/A	Rp0.00M	Rp589.20M	Rp88.42M	Rp308.00M
FCF	Free Cash Flow	N/A	Rp0.00M	Rp199.85M	Rp-,189.06M	Rp-1,010.74M
FCFS	Free Cash Flow Per Share	Rp2.03	Rp0.35	Rp0.27	Rp-0.33	Rp-2.47

Marksans Pharma financials at a glance

Financials

Discover